Contact us contattaci
logo
logo
Corporate Biofarma Group is Top Employer 2024 > Discover more
Biofarma Group
Corporate Biofarma Group formalises 100% acquisition of US Pharma Lab, creating the first global CDMO in the nutraceutical sector > Discover more
Person suffering from the symptoms of irritable bowel syndrome
R&D Innovation Irritable bowel syndrome: Biofarma Group promotes a preclinical study on an anti-inflammatory nutraceutical > Discover more
R&D Innovation Bacterial prostatitis: a study by Biofarma Group demonstrates the anti-inflammatory power of a nutraceutical > Discover more
Image showing some women, target of Respecta product against vaginal dysbiosis
R&D Innovation Vaginal dysbiosis: from Biofarma Group, a product for the health of the microbiota > Discover more
Home / Magazine
prev next

Shaping the Future
Magazine

We believe in knowledge and continuous comparison as essential elements for constant progress.

These values have created Shaping the Future Magazine, a space for information that allows you to enter the world of Biofarma Group, keep up with trends and scientific studies, and learn about new products and the most innovative technologies.

A chance to find out more about us, through what who work with us every day and share our goals say.

12_01_2024 // Corporate

Biofarma Group is Top Employer 2024

Biofarma Group
28_07_2023 // Corporate

Biofarma Group formalises 100% acquisition of US Pharma Lab, creating the first global CDMO in the nutraceutical sector

Person suffering from the symptoms of irritable bowel syndrome
26_06_2023 // R&D Innovation

Irritable bowel syndrome: Biofarma Group promotes a preclinical study on an anti-inflammatory nutraceutical

16_06_2023 // Corporate

Biofarma Group develops its first Biocide for Policlinico Gemelli

29_05_2023 // R&D Innovation

Bacterial prostatitis: a study by Biofarma Group demonstrates the anti-inflammatory power of a nutraceutical

Image showing some women, target of Respecta product against vaginal dysbiosis
29_05_2023 // R&D Innovation

Vaginal dysbiosis: from Biofarma Group, a product for the health of the microbiota

23_05_2023 // R&D Innovation

Supplements for the immune system: the nutraceutical to support the body

18_05_2023 // Corporate

Biofarma Group announces the acquisition of US company US Pharma Lab

04_05_2023 // Corporate

Vitafoods Europe 2023: Biofarma Group at the nutraceuticals event of the year

Integratori per la menopausa: donna con le braccia sollevate
22_03_2023 // R&D Innovation

Supplements for menopause: Biofarma Group’s R&D laboratories to support women’s well-being

01_03_2023 // Corporate

Biofarma Group appoints Gianfranco Nazzi as new CEO

Cosmetica solida e nutricosmetica: immagine di prodotti cosmetici e un fiore in contenitori trasparenti
28_02_2023 // Corporate

Solid and nutraceutic cosmetics: Biofarma Group prepares for Cosmoprof 2023

logo
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000